Physician profile
Shereen Xavier
NPI 1225503212
$1,344.58
in general payments reported to CMS, 2019-2025
5 companies · $571 in 2025
The $571 reported for 2025 was more than what 77% of Primary Care providers received nationally (typical 2025 total: $170).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $96.79 · 2023: $211 · 2024: $466 · 2025: $571.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,248.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,247.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $925.69 | 2023-2025 | Wavewriter Alpha Prime 16, General - Pain Management, Na |
| Globus Medical, INC. | $172.77 | 2025 | Senza |
| Collegium Pharmaceutical, INC. | $111.77 | 2023-2024 | Xtampza, Belbuca |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $96.79 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $37.56 | 2023-2024 | Relistor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shereen Xavier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.